News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Detheux Michel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/10/2023 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 346,000 options to buy
@ $16.66, valued at
$5.8M
Gifted 254,997 options to buy
@ $16.66, valued at
$4.2M
Gifted 254,997 options to buy
@ $16.66, valued at
$4.2M
|
|
| 04/19/2022 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 11,467 shares
@ $31.87, valued at
$365.5k
Sold 33 shares
@ $32.64, valued at
$1.1k
Exercised 11,500 options to buy
@ $4.23, valued at
$48.6k
|
|
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 10,088 shares
@ $35.45, valued at
$357.6k
Sold 4,412 shares
@ $36.21, valued at
$159.8k
|
|
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,500 shares
@ $36.08, valued at
$523.2k
Exercised 16,263 options to buy
@ $12.45, valued at
$202.5k
|
|
| 11/03/2021 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 81 shares
@ $28, valued at
$2.3k
Sold 14,391 shares
@ $28.415, valued at
$408.9k
Sold 6,085 shares
@ $28.887, valued at
$175.8k
|
|
| 10/25/2021 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 196 shares
@ $28.0001, valued at
$5.5k
|
|
| 10/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2020 |
4
| Detheux Michel (CEO) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 1,035,424 options to buy
@ $19, valued at
$19.7M
|
|
|
|